Gilead Sciences
GILD
GILD
1,325 hedge funds and large institutions have $139B invested in Gilead Sciences in 2014 Q3 according to their latest regulatory filings, with 126 funds opening new positions, 465 increasing their positions, 614 reducing their positions, and 51 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
24% less repeat investments, than reductions
Existing positions increased: 465 | Existing positions reduced: 614
36% less call options, than puts
Call options by funds: $2.53B | Put options by funds: $3.96B
Holders
1,325
Holding in Top 10
240
Calls
$2.53B
Puts
$3.96B
Top Buyers
| 1 | +$245M | |
| 2 | +$242M | |
| 3 | +$198M | |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$192M |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$155M |
Top Sellers
| 1 | -$1.65B | |
| 2 | -$1.29B | |
| 3 | -$1.27B | |
| 4 |
Norges Bank
Oslo,
Norway
|
-$989M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$860M |